NgrA activates expression of capsule genes, but not the α-toxin gene in experimental staphylococcus aureus endocarditis

Journal of Infectious Diseases

Volumn 208, Issue 11, 2013, Pages 1841-1848

  Gupta, Ravi Kr ^a   Alba, Jimena ^a   Xiong, Yan Q ^b,c   Bayer, Arnold S ^b,c   Lee, Chia Y ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

toxin; Capsule; Infective endocarditis model; Mgra; Staphylococcus aureus; Virulence

Indexed keywords

STAPHYLOCOCCUS ALPHA TOXIN; BACTERIAL PROTEIN; BACTERIAL TOXIN; CAP5 PROTEIN, STAPHYLOCOCCUS; HEMOLYSIN; STAPHYLOCOCCAL ALPHA-TOXIN; TRANSACTIVATOR PROTEIN; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BACTERIAL ENDOCARDITIS; BACTERIAL GENE; BACTERIAL LOAD; BACTERIAL VIRULENCE; CAP5 GENE; FEMALE; GENE ACTIVATION; GENE EXPRESSION; GENE SEQUENCE; GENETIC REGULATION; GENETIC TRANSCRIPTION; HLA GENE; MGRA GENE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; RAT; SAER GENE; STAPHYLOCOCCUS AUREUS; TRANSCRIPTION REGULATION; Α-TOXIN; ANIMAL; BACTERIAL CAPSULE; CAPSULE; DISEASE MODEL; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; INFECTIVE ENDOCARDITIS MODEL; METABOLISM; MGRA; MICROBIOLOGY; MUTATION; PATHOGENICITY; SPRAGUE DAWLEY RAT; STAPHYLOCOCCUS INFECTION; VIRULENCE;

Α-TOXIN; CAPSULE; INFECTIVE ENDOCARDITIS MODEL; MGRA; STAPHYLOCOCCUS AUREUS; VIRULENCE;

ANIMALS; BACTERIAL CAPSULES; BACTERIAL PROTEINS; BACTERIAL TOXINS; DISEASE MODELS, ANIMAL; ENDOCARDITIS, BACTERIAL; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; HEMOLYSIN PROTEINS; MUTATION; RATS; RATS, SPRAGUE-DAWLEY; SEQUENCE DELETION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TRANS-ACTIVATORS; VIRULENCE; VIRULENCE FACTORS;

EID: 84888580089     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit367     Document Type: Article

References (50)

1. Lowy FD. How Staphylococcus aureus adapts to its host. N Engl J Med 2011; 364:1987-90.
2. El-Ahdab F, Benjamin DK, Wang A, et al. Risk of endocarditis among patients with prosthetic valves and Staphylococcus aureus bacteremia. Am J Med 2005; 118:225-9.
3. Junecko J, Zielinska AK, Mrak LN, et al. Transcribing virulence in Staphylococcus aureus.World J Clin Inf Disease 2012; 2:63-76.
4. Cheung AL, Bayer AS, Zhang G, Gresham H, Xiong YQ. Regulation of virulence determinants in vitro and in vivo in Staphylococcus aureus. FEMS Immunol Med Microbiol 2004; 40:1-9.
5. Cheung AL, Zhang G. Global regulation of virulence determinants in Staphylococcus aureus by the SarA protein family. Front Biosci 2002; 7: d1825-42.
6. Luong TT, Newell SW, Lee CY. Mgr, a novel global regulator in Staphylococcus aureus. J Bacteriol 2003; 185:3703-10.
7. Ingavale SS, Van Wamel W, Cheung AL. Characterization of RAT, an autolysis regulator in Staphylococcus aureus. Mol Microbiol 2003; 48:1451-66.
8. Truong-Bolduc QC, Zhang X, Hooper DC. Characterization of NorR protein, a multifunctional regulator of norA expression in Staphylococcus aureus. J Bacteriol 2003; 185:3127-38.
9. Luong TT, Dunman PM, Murphy E, Projan SJ, Lee CY. Transcription profiling of the mgrA regulon in Staphylococcus aureus. J Bacteriol 2006; 188:1899-910.
10. Ingavale S, van WamelW, Luong TT, Lee CY, Cheung AL. Rat/MgrA, a regulator of autolysis, is a regulator of virulence genes in Staphylococcus aureus. Infect Immun 2005; 73:1423-31.
11. Chen PR, Bae T, Williams WA, et al. An oxidation-sensing mechanism is used by the global regulator MgrA in Staphylococcus aureus. Nat Chem Biol 2006; 2:591-5.
12. Truong-Bolduc QC, Hooper DC. Phosphorylation of MgrA and its effect on expression of the NorA and NorB efflux pumps of Staphylococcus aureus. J Bacteriol 2010; 192:2525-34.
13. Jonsson IM, Lindholm C, Luong TT, Lee CY, Tarkowski A. Mgra regulates staphylococcal virulence important for induction and progression of septic arthritis and sepsis. Microbes Infect 2008; 10:1229-35.
14. O'Riordan K, Lee JC. Staphylococcus aureus capsular polysaccharides. Clin Microbiol Rev 2004; 17:218-34.
15. Lee CY, Lee JC. Staphylococcal capsules. In: Fischetti V, Novick RP, Ferretti J, Portnoy D, Rood J, eds. Gram-positive pathogens. 2nd ed. Washington, DC: American Society for Microbiology, 2006: 456-63.
16. Sau S, Bhasin N, Wann ER, Lee JC, Foster TJ, Lee CY. The Staphylococcus aureus allelic genetic loci for serotype 5 and 8 capsule expression contain the type-specific genes flanked by common genes. Microbiology 1997; 143(Pt 7):2395-405.
17. Luong TT, Lee CY. The arl locus positively regulates Staphylococcus aureus type 5 capsule via an mgrA-dependent pathway. Microbiology 2006; 152:3123-31.
18. Majerczyk CD, Sadykov MR, Luong TT, Lee C, Somerville GA, Sonenshein AL. Staphylococcus aureus CodY negatively regulates virulence gene expression. J Bacteriol 2008; 190:2257-65.
19. Chen Z, Luong TT, Lee CY. The sbcDC locus mediates repression of type 5 capsule production as part of the SOS response in Staphylococcus aureus. J Bacteriol 2007; 189:7343-50.
20. Majerczyk CD, Dunman PM, Luong TT, et al. Direct targets of CodY in Staphylococcus aureus. J Bacteriol 2010; 192:2861-77.
21. Luong TT, Sau K, Roux C, Sau S, Dunman PM, Lee CY. Staphylococcus aureus ClpC divergently regulates capsule via sae and codY in strain Newman but activates capsule via codY in strain UAMS-1 and in strain Newman with repaired saeS. J Bacteriol 2011; 193:686-94.
22. Steinhuber A, Goerke C, Bayer MG, Döring G, Wolz C. Molecular architecture of the regulatory locus sae of Staphylococcus aureus and its impact on expression of virulence factors. J Bacteriol 2003; 185:6278-86.
23. Connelly JC, de Leau ES, Leach DR. DNA cleavage and degradation by the SbcCD protein complex from Escherichia coli. Nucleic Acids Res 1999; 27:1039-46.
24. Sonenshein AL. CodY, a global regulator of stationary phase and virulence in gram-positive bacteria. Curr Opin Microbiol 2005; 8:203-7.
25. Moreillon P, Entenza JM, Francioli P, et al. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun 1995; 63:4738-43.
26. Arvidson S, Janzon L, Lofdahl S. The role of the d-lysin gene (hld) in the agr-dependent regulation of exoprotein synthesis in Staphylococcus aureus. In: Novick RP, ed. Molecular biology of the staphylococci. New York: VCH, 1990:419-31.
27. Goerke C, Fluckiger U, Steinhuber A, Zimmerli W, Wolz C. Impact of the regulatory loci agr, sarA and sae of Staphylococcus aureus on the induction of alpha-toxin during device-related infection resolved by direct quantitative transcript analysis. Mol Microbiol 2001; 40: 1439-47.
28. Vandenesch F, Kornblum J, Novick RP. A temporal signal, independent of agr, is required for hla but not spa transcription in Staphylococcus aureus. J Bacteriol 1991; 173:6313-20.
29. Giraudo AT, Cheung AL, Nagel R. The sae locus of Staphylococcus aureus controls exoprotein synthesis at the transcriptional level. Arch Microbiol 1997; 168:53-8.
30. Janzon L, Arvidson S. The role of the delta-lysin gene (hld) in the regulation of virulence genes by the accessory gene regulator (agr) in Staphylococcus aureus. EMBO J 1990; 9:1391-9.
31. Xiong YQ, Willard J, Yeaman MR, Cheung AL, Bayer AS. Regulation of Staphylococcus aureus alpha-toxin gene (hla) expression by agr, sarA, and sae in vitro and in experimental infective endocarditis. J Infect Dis 2006; 194:1267-75.
32. van Wamel W, Xiong YQ, Bayer AS, Yeaman MR, Nast CC, Cheung AL. Regulation of Staphylococcus aureus type 5 capsular polysaccharides by agr and sarA in vitro and in an experimental endocarditis model. Microb Pathog 2002; 33:73-9.
33. Xiong YQ, Willard J, Kadurugamuwa JL, Yu J, Francis KP, Bayer AS. Real-time in vivo bioluminescent imaging for evaluating the efficacy of antibiotics in a rat Staphylococcus aureus endocarditis model. Antimicrob Agents Chemother 2005; 49:380-7.
34. Lei MG, Cue D, Roux CM, Dunman PM, Lee CY. Rsp inhibits attachment and biofilm formation by repressing fnbA in Staphylococcus aureus MW2. J Bacteriol 2011; 193:5231-41.
35. Luong T, Sau S, Gomez M, Lee JC, Lee CY. Regulation of Staphylococcus aureus capsular polysaccharide expression by agr and sarA. Infect Immun 2002; 70:444-50.
36. Xiong YQ, VanWamel W, Nast CC, Yeaman MR, Cheung AL, Bayer AS. Activation and transcriptional interaction between agr RNAII and RNAIII in Staphylococcus aureus in vitro and in an experimental endocarditis model. J Infect Dis. 2002; 186:668-77.
37. Kirstein J, Molière N, Dougan DA, Turgay K. Adapting the machine: Adaptor proteins for Hsp100/Clp and proteases. Nat Rev Microbiol 2009; 7:589-99.
38. Lee JC, Takeda S, Livolsi PJ, Paoletti LC. Effects of in vitro and in vivo growth conditions on expression of type 8 capsular polysaccharide by Staphylococcus aureus. Infect Immun 1993; 61:1853-8.
39. Baddour LM, Lowrance C, Albus A, Lowrance JH, Anderson SK, Lee JC. Staphylococcus aureus microcapsule expression attenuates bacterial virulence in a rat model of experimental endocarditis. J Infect Dis 1992; 165:749-53.
40. Nemeth J, Lee JC. Antibodies to capsular polysaccharides are not protective against experimental Staphylococcus aureus endocarditis. Infect Immun 1995; 63:375-80.
41. Peterson PK, Wilkinson BJ, Kim Y, Schmeling D, Quie PG. Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes. Infect Immun 1978; 19:943-9.
42. Voyich JM, Braughton KR, Sturdevant DE, et al. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol 2005; 175:3907-19.
43. Luong TT, Lee CY. Overproduction of type 8 capsular polysaccharide augments Staphylococcus aureus virulence. Infect Immun 2002; 70: 3389-95.
44. Nilsson IM, Lee JC, Bremell T, Rydén C, Tarkowski A. The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis. Infect Immun 1997; 65:4216-21.
45. Liang X, Yu C, Sun J, et al. Inactivation of a two-component signal transduction system, SaeRS, eliminates adherence and attenuates virulence of Staphylococcus aureus. Infect Immun 2006; 74:4655-65.
46. Fournier B, Hooper DC. A new two-component regulatory system involved in adhesion, autolysis, and extracellular proteolytic activity of Staphylococcus aureus. J Bacteriol 2000; 182:3955-64.
47. Morfeldt E, Taylor D, vonGabain A, Arvidson S. Activation of alphatoxin translation in Staphylococcus aureus by the trans-encoded antisense RNA, RNAIII. EMBO J 1995; 14:4569-77.
48. Geisinger E, Adhikari RP, Jin R, Ross HF, Novick RP. Inhibition of rot translation by RNAIII, a key feature of agr function. Mol Microbiol 2006; 61:1038-48.
49. Boisset S, Geissmann T, Huntzinger E, et al. Staphylococcus aureus RNAIII coordinately represses the synthesis of virulence factors and the transcription regulator Rot by an antisense mechanism. Genes Dev 2007; 21:1353-66.
50. Sun F, Li C, Jeong D, Sohn C, He C, Bae T. In the Staphylococcus aureus two-component system sae, the response regulator SaeR binds to a direct repeat sequence and DNA binding requires phosphorylation by the sensor kinase SaeS. J Bacteriol 2010; 192: 2111-27.